Drug interactions between buprenorphine, methadone and hepatitis C therapeutics.

about

Management of precipitated opiate withdrawal syndrome induced by nalmefene mistakenly prescribed in opiate-dependent patients: a review for clinicians.Hepatitis C in injection drug users: It is time to treat.

P2860

Q39200931-ACE42040-B42A-455B-A4ED-FF5DCCAF9FF9 Q42345066-50834ADF-3BB2-4A77-93B6-1610E7D84979

P2860

Drug interactions between buprenorphine, methadone and hepatitis C therapeutics.

Item

http://www.wikidata.org/entity/Q38824198

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Drug interactions between buprenorphine, methadone and hepatitis C therapeutics.

@en

type

Item

label

Drug interactions between buprenorphine, methadone and hepatitis C therapeutics.

@en

prefLabel

Drug interactions between buprenorphine, methadone and hepatitis C therapeutics.

@en

P1476

Drug interactions between buprenorphine, methadone and hepatitis C therapeutics.

@en

P2093

Gerald Friedland

http://www.w3.org/2001/XMLSchema#string

Onyema Ogbuagu

http://www.w3.org/2001/XMLSchema#string

R Douglas Bruce

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro activity and preclinical profile of TMC435350, a potent hepatitis C virus protease inhibitor

Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes

New treatment strategies for hepatitis C infection

The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM): the use of direct-acting antivirals as treatment for prevention

Oral antiviral therapies for chronic hepatitis C infection

A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice

Global epidemiology of hepatitis C virus infection

Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence

P304

721-731

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1080/17425255.2016.1183644

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27140427

http://www.w3.org/2001/XMLSchema#string

Drug interactions between buprenorphine, methadone and hepatitis C therapeutics.

about

P2860

P2860

Drug interactions between buprenorphine, methadone and hepatitis C therapeutics.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698